Please assess the completion status of the following clinical trial:

Trial Title: Self-activation in Individuals With and Without Nicotine Dependence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 18-45 years of age~2. Right handed~3. In good general health~4. Male or Female~5. For ND individuals: Self-reported smoking ≥ 5 combustible cigarettes per day~6. For ND individuals: Afternoon expired CO concentration of ≥ 8 ppm~7. For ND individuals: Is willing and able to abstain from smoking for a few hours~Exclusion Criteria:~1. History of chronic/significant medical condition~2. Current or past 6 month use of prescription medications for psychiatric conditions (e.g., depression, anxiety)~3. Current or past 6 month diagnosis of anxiety, bipolar disorder, depression, OCD, schizophrenia, psychosis, or personality disorder.~4. Current substance abuse or dependence or history within the last 6 months (other than nicotine for ND individuals)~5. For ND individuals: Positive drug test for anything other than marijuana~6. For ND individuals: Currently on nicotine replacement therapy~7. For ND individuals: Individuals who role their own cigarettes~8. For ND individuals: Daily cannabis use~9. For ND individuals: Consume more than 21 alcoholic drinks per week~10. For ND individuals: Use harder drugs (e.g., cocaine, methamphetamine) more than 10 times per year~11. For ND individuals: Currently taking medication that directly acts on the dopamine system (e.g., L-DOPA).~12. Inability to understand written and/or spoken English language~13. For MRI subjects: Claustrophobia or other contraindications to MRI scanning~14. For MRI subjects: If female, pregnancy as determined by urine pregnancy test on the day of MRI scanning~15. For MRI subjects: Presence of any metal in the body (e.g., implant, non-removable piercing, metal IUD)~16. For MRI subjects: Head injury resulting in loss of consciousness~17. For MRI subjects: Worked with metal (e.g., welding) or had an injury to the eye involving metal~18. For MRI subjects: Weigh more than 250 pounds

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Reward-related Brain Region Feedback (Type: EXPERIMENTAL): Participants in this group will receive neurofeedback from a reward-related brain area (e.g., VTA, PFC) using EEG and/or fMRI during the experiment.
- Noise Control (Type: SHAM_COMPARATOR): Participants in this group will receive sham neurofeedback. Participants will be debriefed at the end of the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).